28.12.2012 Views

33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ...

33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ...

33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

As noted above, any s<strong>of</strong>t-tissue sarcoma or s<strong>of</strong>t-tissue tumor can arise from breast<br />

connective tissue, but a relatively rare malignant stromal tumor (sarcoma) showing<br />

endothelial-cell differentiation deserves special consideration. This is known as<br />

primary breast angiosarcoma, which can occur de novo within the breast parenchyma<br />

or be secondary in patients following radiation therapy or long after radical<br />

mastectomy complicated by chronic lymphedema (Stewart Treves Syndrome).<br />

Conservative approaches to surgical therapy have largely eliminated Stewart Treves<br />

Syndrome.<br />

Angiosarcoma <strong>of</strong> the breast may be difficult to palpate and to find in mammograms,<br />

but in some cases, a palpable mass may be discernible (142-146). Usually, breast<br />

angiosarcomas produce s<strong>of</strong>t, spongy, and hemorrhagic areas. Tumor cells form<br />

irregular, invasive, anastomosing vascular channels that are lined by atypical<br />

(hyperchromatic) endothelial cells, but the cytologic features may vary, ranging from<br />

a highly undifferentiated solid tumor to one that is very bland cytologically and<br />

difficult to distinguish from benign vessels (142-146). Malignant vessels <strong>of</strong><br />

angiosarcoma invade breast parenchyma diffusely and show no "respect" for normal<br />

breast structures. Some authors have observed the prognosis <strong>of</strong> breast angiosarcoma to<br />

correlate nicely with histologic grade, although traditionally breast angiosarcoma has<br />

been considered to have a universally poor prognosis (144-146). In fact, Rosen and<br />

coworkers report that the overall survival <strong>of</strong> patients with breast angiosarcoma is<br />

roughly <strong>33</strong>% at 5 years, but the majority <strong>of</strong> patients with well-differentiated tumors<br />

will survive 5 years (144, 145). Tumor cells are positive for endothelial markers such<br />

as factor VIII–related antigen (vVF), CD31, and CD34. Some high-grade epithelioid<br />

tumors may mimic carcinoma, but the majority show immunoreactivity for the<br />

aforementioned endothelial markers. The differential diagnosis <strong>of</strong> breast angiosarcoma<br />

includes poorly differentiated breast carcinoma, metaplastic carcinoma, acantholytic<br />

squamous carcinoma, various benign hemangiomas (hemangiomatoses),<br />

hemangiopericytoma, cystic hygroma, cellular angiolipoma, and pseudoangiomatous<br />

stromal hyperplasia (113, 142-156). Cellular angiolipoma may be particularly<br />

troublesome, but it shows hyaline thrombi within cytologically bland capillaries and is<br />

<strong>of</strong>ten well circumscribed. In this spectrum <strong>of</strong> vascular lesions, atypical vascular<br />

lesions, lymphangioma-like nodules, and overt angiosarcomas <strong>of</strong> breast and/or<br />

overlying skin have been reported following segmental resection with edema and after<br />

radiation therapy (116, 117, 157-161). The latter phenomenon is somewhat<br />

reminiscent <strong>of</strong> so-called lymphangiosarcoma <strong>of</strong> the upper extremities as a result <strong>of</strong><br />

long-standing postmastectomy lymphedema (Stewart-Treves syndrome) (142-146).<br />

96

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!